These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pretreatment Endocrine Disorders Due to Optic Pathway Gliomas in Pediatric Neurofibromatosis Type 1: Multicenter Study. Santoro C, Perrotta S, Picariello S, Scilipoti M, Cirillo M, Quaglietta L, Cinalli G, Cioffi D, Di Iorgi N, Maghnie M, Gallizia A, Parpagnoli M, Messa F, De Sanctis L, Vannelli S, Marzuillo P, Miraglia Del Giudice E, Grandone A. J Clin Endocrinol Metab; 2020 Jun 01; 105(6):. PubMed ID: 32294191 [Abstract] [Full Text] [Related]
3. [Optic chiasm glioma in children: Endocrine disorders in 14 cases]. García García E, Márquez Vega C, Fajardo Cascos M, Venegas Moreno E, Soto Moreno A. Med Clin (Barc); 2016 May 20; 146(10):446-9. PubMed ID: 26971985 [Abstract] [Full Text] [Related]
4. Optic pathway gliomas in patients with neurofibromatosis type 1: follow-up of 44 patients. Segal L, Darvish-Zargar M, Dilenge ME, Ortenberg J, Polomeno RC. J AAPOS; 2010 Apr 20; 14(2):155-8. PubMed ID: 20451859 [Abstract] [Full Text] [Related]
7. Precocious and accelerated puberty in children with neurofibromatosis type 1: results from a close follow-up of a cohort of 45 patients. Pinheiro SL, Maciel J, Cavaco D, Figueiredo AA, Damásio IL, Donato S, Passos J, Simões-Pereira J. Hormones (Athens); 2023 Mar 20; 22(1):79-85. PubMed ID: 36269545 [Abstract] [Full Text] [Related]
9. Visual outcomes after chemotherapy for optic pathway glioma in children with and without neurofibromatosis type 1: results of the International Society of Paediatric Oncology (SIOP) Low-Grade Glioma 2004 trial UK cohort. Falzon K, Drimtzias E, Picton S, Simmons I. Br J Ophthalmol; 2018 Oct 20; 102(10):1367-1371. PubMed ID: 29343527 [Abstract] [Full Text] [Related]
10. Optic Pathway Glioma and Cerebral Focal Abnormal Signal Intensity in Patients with Neurofibromatosis Type 1: Characteristics, Treatment Choices and Follow-up in 134 Affected Individuals and a Brief Review of the Literature. Friedrich RE, Nuding MA. Anticancer Res; 2016 Aug 20; 36(8):4095-121. PubMed ID: 27466519 [Abstract] [Full Text] [Related]
11. Growth hormone excess in children with neurofibromatosis type-1 and optic glioma. Cambiaso P, Galassi S, Palmiero M, Mastronuzzi A, Del Bufalo F, Capolino R, Cacchione A, Buonuomo PS, Gonfiantini MV, Bartuli A, Cappa M, Macchiaiolo M. Am J Med Genet A; 2017 Sep 20; 173(9):2353-2358. PubMed ID: 28631895 [Abstract] [Full Text] [Related]
12. Endocrinologic disorders and optic pathway gliomas in children with neurofibromatosis type 1. Cnossen MH, Stam EN, Cooiman LC, Simonsz HJ, Stroink H, Oranje AP, Halley DJ, de Goede-Bolder A, Niermeijer MF, de Muinck Keizer-Schrama SM. Pediatrics; 1997 Oct 20; 100(4):667-70. PubMed ID: 9310522 [Abstract] [Full Text] [Related]
15. Risk of optic pathway glioma in children with neurofibromatosis type 1 and optic nerve tortuosity or nerve sheath thickening. Levin MH, Armstrong GT, Broad JH, Zimmerman R, Bilaniuk LT, Feygin T, Li Y, Liu GT, Fisher MJ. Br J Ophthalmol; 2016 Apr 20; 100(4):510-4. PubMed ID: 26294105 [Abstract] [Full Text] [Related]
16. Neurofibromatosis type 1 and optic pathway gliomas: follow-up of 54 patients. Thiagalingam S, Flaherty M, Billson F, North K. Ophthalmology; 2004 Mar 20; 111(3):568-77. PubMed ID: 15019338 [Abstract] [Full Text] [Related]
17. Prechiasmatic transection of the optic nerve in optic nerve glioma: technical description and surgical outcome. Borghei-Razavi H, Shibao S, Schick U. Neurosurg Rev; 2017 Jan 20; 40(1):135-141. PubMed ID: 27230830 [Abstract] [Full Text] [Related]
18. Reversible Growth Hormone Excess in Two Girls with Neurofibromatosis Type 1 and Optic Pathway Glioma. Bruzzi P, Sani I, Albanese A. Horm Res Paediatr; 2015 Jan 20; 84(6):414-22. PubMed ID: 26488470 [Abstract] [Full Text] [Related]